olaratumab (103)	

Structure	 

Heavy chain / Chaone lourde / Cadena pesada

QLQLQESGPG LVKPSETLSL TCTVSGGSIN SSSYYWGWLR QSPGKGLEWI  50

GSFFYTGSTY YNPSLRSRLT ISVDTSKNQF SLMLSSVTAA DTAVYYCARQ 100

STYYYGSGNY YGWFDRWDQG TLVTVSSAST KGPSVFPLAP SSKSTSGGTA 150

ALGCLVKDYF PEPVTVSWNS GALTSGVHTF PAVLQSSGLY SLSSVVTVPS 200

SSLGTQTYIC NVNHKPSNTK VDKRVEPKSC DKTHTCPPCP APELLGGPSV 250

FLFPPKPKDT LMISRTPEVT CVVVDVSHED PEVKFNWYVD GVEVHNAKTK 300

PREEQYNSTY RVVSVLTVLH QDWLNGKEYK CKVSNKALPA PIEKTISKAK 350

GQPREPQVYT LPPSREEMTK NQVSLTCLVK GFYPSDIAVE WESNGQPENN 400

YKTTPPVLDS DGSFFLYSKL TVDKSRWQQG NVFSCSVMHE ALHNHYTQKS 450

LSLSPGK                                                457

Light chain / Chaone lygire / Cadena ligera

EIVLTQSPAT LSLSPGERAT LSCRASQSVS SYLAWYQQKP GQAPRLLIYD  50

ASNRATGIPA RFSGSGSGTD FTLTISSLEP EDFAVYYCQQ RSNWPPAFGQ 100

GTKVEIKRTV AAPSVFIFPP SDEQLKSGTA SVVCLLNNFY PREAKVQWKV 150

DNALQSGNSQ ESVTEQDSKD STYSLSSTLT LSKADYEKHK VYACEVTHQG 200

LSSPVTKSFN RGEC                                        214

Disulfide bridges location / Position des ponts disulfure / Posiciones
de los puentes disulfuro

Intra-H	22-97	154-210	271-331	377-435

	22??-97??	154??-210??	271??-331??	377??-435??

Intra-L	23?-88?	134?-194?



	23???-88???	134???-194???



Inter-H-L	230-214?	230??-214???



Inter-H-H	236-236??	239-239??





N-glycosylation sites / Sites de N-glycosylation / Posiciones de
N-glicosilaciun

30, 30??, 307, 307??

CAS		1024603-93-7 

Description

immunoglobulin G1-kappa, anti-[Homo sapiens PDGFRA (platelet-derived
growth factor receptor alpha subunit, CD140a, PDGFR2)], Homo sapiens
monoclonal antibody;

gamma1 heavy chain (1-457) [Homo sapiens VH (IGHV4-39*01 (90.90%)
-(IGHD)-IGHJ5*01 G119>D) [10.7.19] (1-127) -IGHG1*03 (128-457)],
(230-214?)-disulfide with kappa light chain (1?-214?) [Homo sapiens
V-KAPPA (IGKV3-11*01 (100.00%) -IGKJ1*01) [6.3.9] (1?-107?) -IGKC*01
(108?-214?)]; (236-236??:239-239??)-bisdisulfide dimer

immunoglobuline G1-kappa, anti-[Homo sapiens PDGFRA (sous-unity alpha du
rycepteur du facteur de croissance dyrivy des plaquettes, CD140a,
PDGFR2)], Homo sapiens anticorps monoclonal;

chaone lourde gamma1 (1-457) [Homo sapiens VH (IGHV4-39*01 (90.90%)
-(IGHD)-IGHJ5*01 G119>D) [10.7.19] (1-127) -IGHG1*03 (128-457)],
(230-214?)-disulfure avec la chaone lygire kappa (1?-214?) [Homo sapiens
V-KAPPA (IGKV3-11*01 (100.00%) -IGKJ1*01) [6.3.9] (1?-107?) -IGKC*01
(108?-214?)]; dimire (236-236??:239-239??)-bisdisulfure 

inmunoglobulina G1-kappa, anti-[Homo sapiens PDGFRA (subunidad alfa del
receptor del factor de crecimiento derivado de las plaquetas, CD140a,
PDGFR2)], Homo sapiens anticuerpo

monoclonal;

cadena pesada gamma1 (1-457) [Homo sapiens VH (IGHV4-39*01 (90.90%)
-(IGHD)-IGHJ5*01 G119>D) [10.7.19] (1-127) -IGHG1*03 (128-457)],
(230-214?)-disulfuro con la cadena ligera kappa (1?-214?) [Homo sapiens
V-KAPPA (IGKV3-11*01 (100.00%) -IGKJ1*01) [6.3.9] (1?-107?) -IGKC*01
(108?-214?)]; dimero (236-236??:239-239??)-bisdisulfuro

	

WHO 

International Nonproprietary Names Programme	

30/06/2010

9308

		

